St. Louis Institute for Nanomedicine
Supported by Missouri Life Sciences Reserach Board, The
St. Louis Institute for Nanomedicine primarily serves to advance the safe and effective use of nanotechnologies to reduce death and suffering from human disease. The Institute will provide resources and infrastructure to facilitate regional interdisciplinary research collaborations by sponsoring:
- Fundamental research of nanoscale materials, structures, devices, and pharmaceuticals for early detection of life-threatening diseases.
- Translational research in the context of nanotoxicology for understanding biological and environmental response to nanomaterials.
- Technology transfer of scientific breakthroughs toward commercialization through an entrepreneurial pathway to connect academia with local industries and ventures.
- Education and workforce development of leaders who will support responsible development of nanotechnology.
For more information, please contact the principal investigator Sam Wickline.